Viewing Study NCT00771251


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT00771251
Status: COMPLETED
Last Update Posted: 2015-11-03
First Post: 2008-10-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR015343
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View